JPS5456685A - Cyclodextrineeencloseddtype complex compounds of prostacycline and derivative thereof* and method of making same - Google Patents

Cyclodextrineeencloseddtype complex compounds of prostacycline and derivative thereof* and method of making same

Info

Publication number
JPS5456685A
JPS5456685A JP11738378A JP11738378A JPS5456685A JP S5456685 A JPS5456685 A JP S5456685A JP 11738378 A JP11738378 A JP 11738378A JP 11738378 A JP11738378 A JP 11738378A JP S5456685 A JPS5456685 A JP S5456685A
Authority
JP
Japan
Prior art keywords
cyclodextrineeencloseddtype
prostacycline
derivative
making same
complex compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11738378A
Other languages
English (en)
Inventor
Suzejitori Jiyozusefu
Suzejitori Magudoruna
Kuse Giyorugii
Sutadoraa Isutoban
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of JPS5456685A publication Critical patent/JPS5456685A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP11738378A 1977-09-23 1978-09-22 Cyclodextrineeencloseddtype complex compounds of prostacycline and derivative thereof* and method of making same Pending JPS5456685A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1770A HU179141B (ja) 1977-09-23 1977-09-23

Publications (1)

Publication Number Publication Date
JPS5456685A true JPS5456685A (en) 1979-05-07

Family

ID=10994670

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11738378A Pending JPS5456685A (en) 1977-09-23 1978-09-22 Cyclodextrineeencloseddtype complex compounds of prostacycline and derivative thereof* and method of making same

Country Status (20)

Country Link
JP (1) JPS5456685A (ja)
AT (1) AT369362B (ja)
BE (1) BE870646A (ja)
CH (1) CH637388A5 (ja)
CS (1) CS200242B2 (ja)
DD (1) DD138600A5 (ja)
DE (1) DE2840142A1 (ja)
DK (1) DK420778A (ja)
FI (1) FI65912C (ja)
FR (1) FR2404006A1 (ja)
GB (1) GB2006193B (ja)
GR (1) GR65001B (ja)
HU (1) HU179141B (ja)
IL (1) IL55569A (ja)
IT (1) IT1160661B (ja)
NL (1) NL7809643A (ja)
PL (1) PL121664B1 (ja)
SE (1) SE447574B (ja)
SU (1) SU847914A3 (ja)
YU (1) YU220678A (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
DE3740838A1 (de) * 1987-11-27 1989-06-08 Schering Ag Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
WO2005073223A1 (ja) 2004-01-29 2005-08-11 Eisai R & D Management Co., Ltd. マクロライド系化合物の安定化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (ja) * 1970-06-10 1975-02-04
US3953435A (en) * 1974-01-10 1976-04-27 Ono Pharmaceutical Company Aldehyde derivatives of prostaglandins
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds

Also Published As

Publication number Publication date
GB2006193A (en) 1979-05-02
YU220678A (en) 1983-10-31
PL121664B1 (en) 1982-05-31
CH637388A5 (de) 1983-07-29
FI65912C (fi) 1984-08-10
BE870646A (fr) 1979-01-15
HU179141B (ja) 1982-08-28
IT7869160A0 (it) 1978-09-19
DD138600A5 (de) 1979-11-14
FI782878A (fi) 1979-03-24
SE447574B (sv) 1986-11-24
ATA677478A (de) 1982-05-15
AT369362B (de) 1982-12-27
SE7809946L (sv) 1979-03-24
DK420778A (da) 1979-03-24
NL7809643A (nl) 1979-03-27
SU847914A3 (ru) 1981-07-15
FR2404006A1 (fr) 1979-04-20
GR65001B (en) 1980-06-12
FI65912B (fi) 1984-04-30
IT1160661B (it) 1987-03-11
FR2404006B1 (ja) 1981-07-31
PL209773A1 (pl) 1979-06-04
IL55569A (en) 1981-12-31
CS200242B2 (en) 1980-08-29
DE2840142A1 (de) 1979-04-05
IL55569A0 (en) 1978-12-17
GB2006193B (en) 1982-05-26

Similar Documents

Publication Publication Date Title
JPS54145699A (en) 133halo and 133deoxy derivative of cc076 compound
BG28703A3 (en) Method of obtaining of momatostatine derivatives
JPS5422208A (en) Method of photogravuring
JPS53137992A (en) Nnalkyllnnacyl derivative of thienamycine
BG28700A3 (en) Method of obtaining of alkylendiamine derivatives
JPS5481304A (en) Severe method of property improvement
BG33278A3 (en) Method for making of carbamide derivatives
GB1553661A (en) P-amino-methyl-benzene-sulphonamide derivatives process for their preparation and application thereof
JPS5456685A (en) Cyclodextrineeencloseddtype complex compounds of prostacycline and derivative thereof* and method of making same
JPS5490124A (en) Method of reduction
JPS53130699A (en) 44deoxyvlbba and b and 33oxidized derivative of related 11formyl compound
JPS549154A (en) Forgeddjoint and method of forming same
JPS53121741A (en) Derivative of cyclobutane * its preparation and method for using said compound
JPS5486522A (en) Pyrazoline compound and method of making same
JPS53119833A (en) Method of purieying ppphenylenediamine
JPS53128194A (en) Method of preventing smoke
JPS5399316A (en) Stbilyzing method of leserpine preparation
JPS53141027A (en) Method of preventing
JPS5457599A (en) Polyparabanic acid derivative* method of making same and use thereof
JPS53112894A (en) Method of etherizing
JPS53132540A (en) Derivative of 88dehydroovitaminna and method of its production
BG30018A3 (en) Method for obtaining of substituated hinolisidine and indolisidine derivatives
JPS53137993A (en) Nnalkyllnniminomethyl derivative of thienamycine
JPS53105495A (en) Method of deesterizing cephalospoline
JPS53100620A (en) Method of connecting hhbeam